Literature DB >> 3013680

Inhibition of catalytic unit of adenylate cyclase and activation of GTPase of Ni protein by beta gamma-subunits of GTP-binding proteins.

K Enomoto, T Asakawa.   

Abstract

A protein factor which inhibited adenylate cyclase was purified to apparent homogeneity from rat brain and identified as the beta gamma-subunits of the GTP-binding regulatory proteins of adenylate cyclase. (i) The beta gamma-subunits (protein factor) inhibited the partially purified catalytic unit of adenylate cyclase in the presence of an activator, forskolin or the stimulative regulatory protein (Ns), to 60 and 40% of the control, respectively; inhibition of the catalytic unit in the presence of forskolin required no guanine nucleotides. (ii) The subunits enhanced the GTPase activity of the purified alpha-subunit of the inhibitory regulatory protein (Ni alpha) 3.8-fold. (iii) The subunits stimulated ADP-ribosylation of Ni alpha catalyzed by islet-activating protein (pertussis toxin). ADP-ribosylation had no effect on the GTPase activity of Ni alpha in the presence of the beta gamma-subunits. The results suggest that direct inhibition of the catalytic unit by the beta gamma-subunits liberated from Ni is essential for the receptor-mediated inhibition of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013680     DOI: 10.1016/0014-5793(86)80650-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  G proteins as regulators of ion channel function.

Authors:  Kathleen Dunlap; George G Holz; Stanley G Rane
Journal:  Trends Neurosci       Date:  1987-06-01       Impact factor: 13.837

2.  Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits.

Authors:  P A Cahill; Y Wu; J V Sitzmann
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

3.  Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.

Authors:  A M Feldman; A E Cates; W B Veazey; R E Hershberger; M R Bristow; K L Baughman; W A Baumgartner; C Van Dop
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.